NAGK is involved in both the de novo and salvage pathways of amino sugar metabolism . In the de novo pathway, GlcNAc is synthesized starting from glycolysis at fructose 6-phosphate . In the salvage pathway, NAGK reutilizes GlcNAc from nutritional sources or lysosomal degradation of oligosaccharides . The phosphorylation of GlcNAc by NAGK is the initial step in the salvage pathway, leading to the formation of GlcNAc-6-phosphate .
GlcNAc-6-phosphate can then enter various metabolic pathways:
NAGK is a prominent salvage enzyme in amino sugar metabolism in mammals . It has been shown to interact with other proteins such as STK16 and LNX1 and also exhibits ManNAc kinase activity . The enzyme’s activity is essential for maintaining the balance of GlcNAc levels in the body, which is crucial for various cellular functions, including glycoprotein metabolism and cartilage repair .
Recombinant human NAGK is produced using genetic engineering techniques to express the human NAGK gene in a host organism, such as bacteria or yeast. This allows for the production of large quantities of the enzyme for research and therapeutic purposes. Recombinant NAGK is used in various biochemical studies to understand its function and role in amino sugar metabolism .